Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
startups
4
×
boston
boston blog main
boston top stories
clinical trials
national top stories
new york blog main
new york top stories
third rock ventures
vc
adeno-associated virus
alnylam
antisense oligonucleotide
arena pharmaceuticals
artie suckow
azacitidine
benzodiazepines
beta-thalassemia
biogen
blackstone group
blackstone life sciences
cancer
chemotherapy
cisplatin
columbia university
dacogen
david goldstein
deals
decibel therapeutics
decitabine
depression
dna
drug delivery
dtx pharma
epi4k
epigenetics
epilepsy
What
drugs
4
×
medicines
4
×
new
aims
research
therapeutics
adding
advance
ago
aiming
approach
backed
balance
based
biologics
biotech
build
called
cause
ceo
considered
debuts
decibel
deliver
developing
diseases
dtx
emerged
epigenetic
epigenetics
epilepsy
field
flagship’s
focus
forms
genes
genetic
hearing
hitting
links
Language
unset
4
×
Current search:
unset
×
startups
×
medicines
×
drugs
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
